
Defender Pharmaceuticals
Defender Pharmaceuticals, Inc.: Developing anti-nausea solutions for human and veterinary markets.
- 30
- Series D
Defender Pharmaceuticals, Inc., founded in St. Louis, Missouri, is a development-stage pharmaceutical company dedicated to discovering, developing, and partnering on anti-vomiting and anti-nausea compounds. The company's core mission is to provide effective solutions for motion sickness and major depressive disorder (MDD) for both human and veterinary markets. Defender Pharmaceuticals aims to enhance the quality of life for its users through innovative therapeutic products.
Notable figures associated with Defender Pharmaceuticals include leading scientists and industry experts in pharmacology and biotechnology. The company has achieved significant milestones in its pipeline development, particularly in addressing motion sickness and MDD. Its impact is seen in its commitment to advancing healthcare solutions that cater to both human and animal needs, positioning itself as a crucial player in the pharmaceutical industry.
Similar Companies

Vm Discovery
vmdiscovery.com

Amerigen Pharmaceuticals
amerigenpharma.com

Mojave Pharma

Fidelis Pharmaceuticals
fidelisrx.com

DMK Pharmaceuticals

Venatorx Pharmaceuticals
venatorx.com

Fennec Pharmaceuticals
fennecpharma.com

Vanda Pharmaceuticals
vandapharma.com

Kiniksa Pharmaceuticals
kiniksa.com

WayPath Pharma
waypathpharma.com
Guardian Biosciences
Companion Pharma

Tioga Pharmaceuticals
tiogapharma.com
Memento Care
mementocare.life
Patients' & Consumers' Pharma
Quick Facts
Who are Defender Pharmaceuticals' competitors?
Companies similar to Defender Pharmaceuticals include Vm Discovery, Amerigen Pharmaceuticals, Mojave Pharma and Fidelis Pharmaceuticals.
Where is Defender Pharmaceuticals' headquarters located?
Defender Pharmaceuticals' headquarters is located in St. Louis, MO, US.
When was Defender Pharmaceuticals' last funding round?
Defender Pharmaceuticals' most recent funding round was for $70M (USD) in July 2023.
How much disclosed funding has Defender Pharmaceuticals raised?
As of Jul 18, 2023, Defender Pharmaceuticals has disclosed funding of $70M (USD). Undisclosed round amounts are excluded.
How many employees does Defender Pharmaceuticals have?
Defender Pharmaceuticals has 30 employees as of Feb 4, 2024.
Classification
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
Show 13 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 620000Health Care and Social Assistance
- 541000Professional, Scientific, and Technical Services
- 623000Nursing and Residential Care Facilities
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research